« April Recipe of the Month | Main | DSM Cuts New CMO Deal With Aussie Government »

05/03/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b01348059461c970c

Listed below are links to weblogs that reference New Sales Leader Expected In Pharmaceutical Clubhouse in 2016 - Humira:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

Bruce Lehr

Here's thepharmaletter's take on the same story. It's funny to see Pfizer being touted to reign supreme with their CAGR from 2009-2016 being projected at -2% - "growing" from $55.3 B to $47.1 B (huh?). I'm not sure "reign supreme" would be adjective I'd use - especially if I'm a stockholder - which I'm not.
http://bit.ly/ausf4Y

Bruce Lehr

More on this topic from the WSJ blog. http://bit.ly/cHvSoN

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

July 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada